Vanguard Capital Management
GOVX icon

Vanguard Capital Management’s GeoVax Labs GOVX Stock Holding History

Vanguard Capital Management’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Hold
3,217
– – ﹤0.01% 4071
2026
Q1 		$4.44K Buy
+3,217
New +$7.7K ﹤0.01% 4038

Other funds holding GOVX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management's GOVX Position: Q2 2026 in Review

Vanguard Capital Management held its GeoVax Labs (GOVX) position steady in Q2 2026 at 3,217 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4071.

Vanguard Capital Management first reported a position in GOVX in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.44K in Q1 2026. 18 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • Vanguard Capital Management held 3,217 shares of GeoVax Labs worth $4.09K as of Q2 2026.
  • Vanguard Capital Management left its GeoVax Labs share count unchanged in Q2 2026.
  • GeoVax Labs made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4071 holding.
  • Vanguard Capital Management first reported a position in GeoVax Labs in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's GeoVax Labs position peaked at $4.44K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.